Pathological Findings of Fatal COVID-19

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

April 22, 2020

Primary Completion Date

March 3, 2021

Study Completion Date

March 3, 2021

Conditions
SARS-CoV-2Covid19PathologyIntensive Care UnitsRespiratory Distress Syndrome
Interventions
OTHER

2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks

All specimens are fixed with 4% neutral formaldehyde and embedded in paraffin wax in the department of pathology of each participating centre. Afterwards, all samples are sent for analysis to the department of pathology of Nantes university hospital. All biopsies are independently analysed by a group of pathologists who are experts in lung tissue and blinded to clinical information. All biopsies will be analysed using a predetermined semi-quantitative histological scoring grid. The pathologists are asked to assess the degree of: edema, cell necrosis, hyaline membrane formation, proliferation of alveolar type 2 cells, fibrosis, capillary congestion, alveolar edema, neutrophilic infiltration, and microscopic thrombosis. Finally, the following patterns are recorded: exudative diffuse alveolar damage (DAD), proliferative DAD, fibrosis, intra-alveolar haemorrhage, lymphocytic pneumonia, organizing pneumonia, acute fibrinous organizing pneumonia (AFOP), thrombotic microangiopathy.

Trial Locations (44)

44000

Nantes University Hospital, Nantes

Unknown

CH Amiens, Amiens

Angers University Hospital, Angers

CH Angoulême, Angoulême

CH Annecy, Annecy

Hopital Privé d'Antony, Antony

CH Argenteuil, Argenteuil

CH Belfort, Belfort

CHU Bordeaux, Bordeaux

Hopital Sainte Camille, Bry-sur-Marne

CH Cahors, Cahors

CH Cergy Pontoise, Cergy-Pontoise

CH Cholet, Cholet

CHU Clermont-Ferrand, Clermont-Ferrand

CH Compiègne-Noyon, Compiègne

CHD Vendée, La Roche-sur-Yon

Hopital Lyon Sud, Lyon

Hôpital Lyon Sud, Lyon

Marseille Hopital Nord APHM, Marseillette

CH Melun, Melun

CH Montélimar, Montélimar

CHU Nice, Nice

CHR Orléans, Orléans

CH Ambroise Paré APHP, Paris

GHEF Marne La Vallée, Paris

Hopital Antoine Béclère APHP, Paris

Hopital Cochin APHP, Paris

Hopital Georges Pompidou APHP, Paris

Hopital La Pitié Salpetrière APHP, Paris

Hopital Louis Mourier APHP, Paris

Hopital Necker APHP, Paris

Hopital Saint-Antoine APHP, Paris

Hopital Saint-Louis APHP, Paris

CH Poissy, Poissy

Hopital Privé Claude Galien, Quincy-sous-Sénart

CH Reims, Reims

CHU Rennes, Rennes

CH Saint-Brieuc, Saint-Brieuc

CHU Saint-Etienne, Saint-Etienne

Hopital Foch, Suresnes

CHRU Tours, Tours

CH Troyes, Troyes

CH Vannes, Vannes

CH Versailles, Versailles

All Listed Sponsors
collaborator

National Research Agency, France

OTHER

lead

Nantes University Hospital

OTHER

NCT04675281 - Pathological Findings of Fatal COVID-19 | Biotech Hunter | Biotech Hunter